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We report the case of a 70-year-old woman who consulted for recurrent short episodes of mild-to-moderate abdominal pain.
Dilated main pancreatic duct was seen on CAT scan and magnetic resonance, with multiple calcifications and intraductal stones,
typical in CP. However, for a more pronounced cystic dilatation in the pancreatic head, we could not exclude the coexistence of
a main duct IPMN. ERCP was performed, with pancreatic sphincterotomy and extraction of pancreatic stones, but, at the same
time, mucin extrusion was seen from the dilated duct through the papilla. Pancreatoduodenectomy was performed. Surgery and
histology confirmed malignant IPMN with the typical image of chronic pancreatitis and intraductal stones in the vicinity. The
patient is doing well 4 years after the surgery, without recurrence of the malignant disease, with changes of chronic pancreatitis
in the pancreatic remnant. This paper discusses the possible relationships between the two entities and emphasizes the need of
differential diagnosis.
1. Introduction
Chronic pancreatitis is a chronic inflammatory disease of
the pancreas, frequently with a benign clinical course. The
diagnosis of the advanced forms is generally easy thanks
to characteristic morphologic findings: irregularly dilated
main pancreatic duct with intraductal stones, calcifications,
and frequent dilation of branch ducts [1]. CP can also be
complicated by pseudocysts, sometimes communicated to
the main duct.
In contrast, intraductal papillary mucinous neoplasia
(IPMN) is a mucin-producing tumor of ductal origin, with
variable probability of malignant transformation. In the
case of main duct IPMN, high-grade dysplasia and even
invasive cancer are already present in 50–70% of lesions
when diagnosed [2, 3] and this frequency is increasing.
Differential diagnosis is based on CAT scan and magnetic
resonance images (MRI): presence of pancreatic stones,
diffuse dilatation of the main duct with “chain of lakes”
images, and dilated branch ducts argue in favor of CP, while
more circumscribed and larger cystic lesions, particularlywith
mural nodules, are frequent in themain duct IPMN.The ther-
apy of the two diseases is quite different: conservative treat-
ment orminimally invasive endoscopic procedures in CP and
radical surgical resolution in main duct IPMN, with a
relatively good prognosis of about 70% survival at 5 years [2].
However, differential diagnosis can be difficult, particu-
larly if calcifications are present in the dilated duct.
We report the case of our patient, in whom CP and
main duct IPMN were simultaneously detected and treated
successfully by surgery.
2. Case Report
A 70-year-old female patient consulted medical doctor for
recurrent moderate abdominal pain in the last few months.
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Figure 1: CAT scan ((a) and (b)) and magnetic resonance ((c) and (d)) images before the surgery. (a) Pancreatic head increased in size, with
focal calcification, without mass lesion. (b) Dilated pancreatic duct in the whole pancreas, with major diameter, and fusiform dilatation in
the pancreatic head. Slight atrophy of pancreatic parenchyma. (c) Fusiform dilated main pancreatic duct in the pancreatic head, with small
filling defect suspected. (d) Dilated main pancreatic duct in pancreatic body and tail, with slight atrophy of parenchyma.
She had had a cholecystectomy 30 years ago; later on, without
significant illness in medical history, she was a teetotaler and
she smoked 2 cigarettes per day during 10 years but stopped
completely during the 6 lastmonths. Routine blood tests were
in the normal range. Abdominal ultrasound did not visualize
the pancreas well due to bloating. A CAT scan was per-
formed, findingmultiple calcifications and irregularly dilated
main pancreatic duct, predominantly in the pancreatic head
(Figures 1(a) and 1(b)), where the dilatation had some
cystic aspect and was disproportionally more pronounced
than in the pancreatic body and tail. The same alterations
were confirmed by MRI (Figures 1(c) and 1(d)), without
intramural nodules in the dilated main duct. Based on the
two imaging methods, we could not distinguish between
chronic calcifying pancreatitis and mucin-producing neo-
plasia, that is, main duct IPMN. ERCP was performed,
and contrast injection revealed a cystic dilation of main
pancreatic duct in the head (Figure 2(a)).Theduct ofWirsung
was less dilated in the body.Through pancreatic papillotomy,
typical whitish pancreatic stone passed into the duodenal
lumen (Figure 2(b)). However, after having continued the
contrast injection, mucin passage was seen producing the
typical fish eye appearance in the major and also the minor
papilla (Figures 2(c) and 2(d)). Simultaneous existence of CP
with pancreatic stones and main duct IPMN was our final
diagnosis. Given the high probability of malignancy in
the dominant cystic lesion, surgery was decided and per-
formed. Surgery revealed a cystic tumor that was found in
a fibrotic pancreas. Pancreatoduodenectomy was performed
with preservation of pylorus and pancreaticogastrostomy.
Some whitish pancreatic stones were extracted. No lymph
node metastasis was seen. Histological (Figure 3) findings
confirmed the existence of a mucinous tumor emerging
from the main pancreatic duct, with multiple foci of high
grade dysplasia and even with evident transformation into
an infiltrative malignant lesion (Figure 3). No lymph node
metastasis or vascular involvement was found. Fibrosis,
acinar cell degeneration, and tubular complexes [4] were seen
in the surrounding tumor-free pancreatic tissue. The patient
is still doing well 4 years after the intervention, without
suspicion of any tumor recurrence.
3. Discussion
IPMN is recognized with increasing frequency, thanks to the
general accessibility of imaging methods, as an incidental
finding in the vast majority of cases. These mucinous benign
tumors generally originate in the branch ducts. Main duct
IPMN is far less frequent but amuchmore severe entity for its
high probability of malignant transformation. Furthermore,
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Figure 2: ERCP. (a) ERCP: incomplete contrast injection in the pancreatic duct. Cystic dilatation of the main pancreatic duct in the head
of pancreas; initial opacification of less dilated duct in the body. Note normal caliber duct in uncinated process. (b) Pancreatic papillotomy,
followed by passage of white pancreatic stone. Nomucin was seen at this moment. (c) “Fish eye” sign; mucin spurring from theminor papilla.
(d) Flow of mucin from the minor papilla.
in some cases, it is difficult to distinguish between CP and
IPMN and the two entities can coexist in the same pancreas
[5–9].
The presence of histological alterations of focal chronic
pancreatitis near to any pancreatic tumor is a usual finding,
but calcification is only exceptionally present. If calcifica-
tion is seen, one can hypothesize 3 possibilities. (1) The
first hypothesis is calcification of the tumor, frequent as a
central scare in benign serous cystadenomas and peripheral
in malignant mucinous cystadenoma. However, in these
cases, the calcification is present in the tumor and not in
the focal chronic pancreatitis. (2) The second hypothesis
is calcification, where intraductal stones can be part of a
preexistent chronic pancreatitis and the main duct IPMN
can develop in a previously ill pancreas. In effect, the risk
of pancreatic adenocarcinoma is higher in CP, but it is a
ductal adenocarcinoma and not an IPMN with malignant
transformation. (3) The third hypothesis is that IPMN, like
all pancreatic tumors, can produce a focal CP, probably
by partial obstruction. However, obstructive CP generally
does not present stones. Zapiach et al. [5] analyzed possible
mechanisms of calcification seen in their 10 patients and they
found this last mechanism as a possible explanation: long-
lasting partial ductal obstruction could be the cause of the
stone formation in this special form of human obstructive
pancreatitis. Our case seems to be in line with this hypothesis:
the medical history of our patient was relatively short; some
months, she had no symptoms of chronic pancreatitis earlier
and she had none of the known etiological factors of the
disease. Probably the slowly growing main duct IPMN was
the cause of her obstructive pancreatitis with subsequent
stone formation.
Our case, while not unique, seems to be rare, given the
simultaneous presence of radiological signs of CP with intra-
ductal stones and a malignant IPMN. Endoscopic therapy,
extraction of stones, could have been a good therapeutic
option for the recurrent pain produced by CP. On the other
hand, the only curative possibility for a main duct IPMN
is radical surgery [10]. Although malignant, as in our case,
the prognosis is quite different from ductal adenocarcinoma,
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Figure 3: Histologic findings. Hematoxylin-eosin, 100x. (a) Neoplastic epithelium of a pancreatic duct, with formation of papillary structures
(on the right). Abundantmucin formation on the left side. (b)Mucinous uniform cells with epithelial atypia and invasion of the neighborhood.
(c) Tumor-free pancreatic tissue. Distortion of the normal architecture; moderate-to-severe fibrosis is seen with inflammatory cell infiltration.
We can observe dilated ductal elements and atrophy of acinar cells.
with>70%of 5-year survival. In our case, ERCPfindingswere
also equivocal, even including pancreatic stone extraction,
but finally the mucin extrusion from the papillary orifice
after manipulation in the pancreatic duct permitted the final
preoperative diagnosis and the correct choice of surgical
therapy.
Our case emphasizes again the possibility that IMPN
and chronic pancreatitis may coexist in the same patient.
Morphologic signs of CP, even the presence of intraductal
stones, are not enough to exclude the simultaneous presence
of main duct IPMN. If radiological findings are not clear
enough [11] and the suspicion of a focal lesion persists, every
possible effort must be made to reach a precise diagnosis,
since the distinction between these two entities is of vital
importance for the patient. In our case, we considered a high
probability of CP without IPMN on the basis of CT andMRI.
ERCP was thus chosen as first procedure with diagnostic and
therapeutic purposes. However, EUS and fine-needle biopsy
could be also the first, less invasive step.The finding of mucin
defined the nature of the lesion without any other procedure,
but in some cases EUS, fine-needle biopsy, and ERCP could
be necessary to establish the final diagnosis.
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